MK-1942
Total Payments
$325,110
Transactions
44
Doctors
4
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $324,006 | 37 | 4 |
| 2019 | $1,104 | 7 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $318,297 | 28 | 97.9% |
| Consulting Fee | $6,813 | 16 | 2.1% |
Payments by Type
Research
$318,297
28 transactions
General
$6,813
16 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Pharmacokinetics of MK-1942 Administered to Alzheimer s Disease Patients Receiving Donepezil Treatment | Merck Sharp & Dohme Corporation | $144,946 | 0 |
| A Randomized, Double Blind, Placebo-Controlled Investigation of the Safety, Tolerability, and Pharmacokinetics of Multiple-Dose Regimens of MK-1942 | Merck Sharp & Dohme Corporation | $139,251 | 0 |
| A Phase 2a, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression | Merck Sharp & Dohme Corporation | $34,100 | 0 |
Top Doctors Receiving Payments for MK-1942
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Glendale, CA | $318,297 | 28 |
| , M.D., PH.D | Psychiatry | New Haven, CT | $3,613 | 7 |
| , MD | Psychiatry | Philadelphia, PA | $2,250 | 6 |
| , M.D | Family Medicine | Little Rock, AR | $700.00 | 2 |
| , MD | Psychiatry | Tampa, FL | $250.00 | 1 |
Ad
Manufacturing Companies
- Merck Sharp & Dohme Corporation $325,110
Product Information
- Type Drug
- Total Payments $325,110
- Total Doctors 4
- Transactions 44
About MK-1942
MK-1942 is a drug associated with $325,110 in payments to 4 healthcare providers, recorded across 44 transactions in the CMS Open Payments database. The primary manufacturer is Merck Sharp & Dohme Corporation.
Payment data is available from 2019 to 2020. In 2020, $324,006 was paid across 37 transactions to 4 doctors.
The most common payment nature for MK-1942 is "Unspecified" ($318,297, 97.9% of total).
MK-1942 is associated with 3 research studies, including "A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Pharmacokinetics of MK-1942 Administered to Alzheimer s Disease Patients Receiving Donepezil Treatment" ($144,946).